top of page
Search Results
1 item found for "gemcitabine"
- Spliceosome mutations are associated with clinical response in a phase 1b/2 study of the PLK1 inhibitor onvansertib in combination with decitabine in relapsed or refractory acute myeloid leukemia
with clinical response in a phase 1b/2 study of the PLK1 inhibitor onvansertib in combination with decitabine A phase 1b trial of the PLK1 inhibitor onvansertib (ONV) combined with decitabine (DAC) demonstrated
bottom of page